Immunoadsorption in dermatology

Archives of Dermatological Research

Volumn 302, Issue 4, 2010, Pages 241-253

  Schmidt, Enno ^a   Zillikens, Detlef ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Autoantibody; Immunoapheresis; Pemphigoid; Pemphigus; Treatment

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CALCIUM; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DAPSONE; DEXAMETHASONE; DOXYCYCLINE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB;

ABSENCE OF SIDE EFFECTS; ALLERGY; ANAPHYLAXIS; ANTIBODY BLOOD LEVEL; AUTOIMMUNE DISEASE; BRADYCARDIA; BULLOUS PEMPHIGOID; BULLOUS SKIN DISEASE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DESMOSOME; DIVERTICULOSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EPIDERMOLYSIS BULLOSA ACQUISITA; FATALITY; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; HERPES ZOSTER; HUMAN; HYPOTENSION; IMMUNOADSORPTION; INFECTION; INTERMETHOD COMPARISON; LOW DRUG DOSE; LUNG EMBOLISM; PARANEOPLASTIC PEMPHIGUS; PARESTHESIA; PEMPHIGOID; PEMPHIGOID GESTATIONIS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PLASMAPHERESIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RELAPSE; REMISSION; REVIEW; SINGLE DRUG DOSE; STAPHYLOCOCCAL BACTEREMIA; TREATMENT CONTRAINDICATION; UNSPECIFIED SIDE EFFECT;

ANIMALS; AUTOANTIBODIES; DERMATOLOGY; EUROPE; HUMANS; IMMUNE COMPLEX DISEASES; IMMUNOSORBENT TECHNIQUES; PLASMAPHERESIS; PRACTICE GUIDELINES AS TOPIC; SKIN DISEASES, VESICULOBULLOUS;

EID: 77952238063     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-009-1024-9     Document Type: Review

References (82)

1. M Amagai T Hashimoto N Shimizu T Nishikawa 1994 Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus J Clin Invest 94 1 59 67 10.1172/JCI117349 1:CAS:528:DyaK2cXltlaisLg%3D 8040292
2. M Amagai T Hashimoto KJ Green N Shimizu T Nishikawa 1995 Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus J Invest Dermatol 104 6 895 901 10.1111/1523-1747.ep12606168 1:CAS:528:DyaK2MXmslCrtbk%3D 7539469
3. M Amagai S Ikeda H Shimizu H Iizuka K Hanada S Aiba F Kaneko S Izaki K Tamaki Z Ikezawa M Takigawa M Seishima T Tanaka Y Miyachi I Katayama Y Horiguchi S Miyagawa F Furukawa K Iwatsuki M Hide Y Tokura M Furue T Hashimoto H Ihn S Fujiwara T Nishikawa H Ogawa Y Kitajima K Hashimoto 2009 A randomized double-blind trial of intravenous immunoglobulin for pemphigus J Am Acad Dermatol 60 4 595 603 10.1016/j.jaad.2008.09.052 19293008
4. GJ Anhalt RS Labib JJ Voorhees TF Beals LA Diaz 1982 Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease N Engl J Med 306 20 1189 1196 1:STN:280:DyaL387ntlSntA%3D%3D 7040962
5. GJ Anhalt 2004 Paraneoplastic pemphigus J Investig Dermatol Symp Proc 9 1 29 33 10.1111/j.1087-0024.2004.00832.x 14870982 (Pubitemid 38096195)
6. F Bertram EB Brocker D Zillikens E Schmidt 2009 Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany J Dtsch Dermatol Ges 7 5 434 440 19170813
7. N Braun T Bosch 2000 Immunoadsorption, current status and future developments Expert Opin Investig Drugs 9 9 2017 2038 10.1517/13543784.9.9.2017 1:CAS:528:DC%2BD3cXmsVKmtbo%3D 11060790
8. JC Bystryn NM Steinman 1996 The adjuvant therapy of pemphigus: an update Arch Dermatol 132 2 203 212 10.1001/archderm.132.2.203 1:STN:280: DyaK283isFKquw%3D%3D 8629830 (Pubitemid 26058511)
9. C Chams-Davatchi M Valikhani M Daneshpazhooh N Esmaili K Balighi Z Hallaji M Barzegari M Akhiani Z Ghodsi H Mortazavi Z Naraghi 2005 Pemphigus: analysis of 1209 cases Int J Dermatol 44 6 470 476 10.1111/j.1365-4632.2004. 02501.x 15941433 (Pubitemid 40867550)
10. JA Cotterill DJ Barker LG Millard 1978 Plasma exchange in the treatment of pemphigus vulgaris Br J Dermatol 98 2 243 10.1111/j.1365-2133.1978.tb01631.x 1:STN:280:DyaE1c7isVSgsA%3D%3D 629881
11. R Eming J Rech S Barth JR Kalden G Schuler T Harrer M Hertl 2006 Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption Dermatology 212 2 177 187 10.1159/000090659 16484825 (Pubitemid 43260734)
12. SB Felix A Staudt 2008 Immunoadsorption as treatment option in dilated cardiomyopathy Autoimmunity 41 6 484 489 10.1080/08916930802031173 1:CAS:528:DC%2BD1cXhtFajsbrK 18781476
13. J Freedman MB Garvey 2004 Immunoadsorption of factor VIII inhibitors Curr Opin Hematol 11 5 327 333 10.1097/01.moh.0000139998.68132.d2 1:CAS:528:DC%2BD2cXhtVWktbfK 15666656 (Pubitemid 40221049)
14. N Frost G Messer G Fierlbeck T Risler SD Lytton 2005 Treatment of pemphigus vulgaris with protein A immunoadsorption: case report of long-term history showing favorable outcome Ann N Y Acad Sci 1051 591 596 10.1196/annals.1361.103 16126999 (Pubitemid 41362786)
15. M Gaubitz KM Schneider 2003 Immunoadsorption in systemic lupus erythematosus: different techniques and their current role in medical therapy Ther Apher Dial 7 2 183 188 10.1046/j.1526-0968.2003.00040.x 12918941 (Pubitemid 36753914)
16. H Genberg G Kumlien L Wennberg G Tyden 2007 Long-term results of ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab Transplantation 84 12 Suppl S44 S47 10.1097/01.tp.0000296031. 41424.f8 1:CAS:528:DC%2BD2sXhsVOgtrvM 18162990
17. H Genberg G Kumlien L Wennberg U Berg G Tyden 2008 ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up Transplantation 85 12 1745 1754 10.1097/TP.0b013e3181726849 1:CAS:528:DC%2BD1cXns1OgtL8%3D 18580466
18. JC Guillaume JC Roujeau P Morel MS Doutre B Guillot D Lambert P Lauret G Lorette F Prigent R Triller, et al. 1988 Controlled study of plasma exchange in pemphigus Arch Dermatol 124 11 1659 1663 10.1001/archderm.124.11.1659 1:STN:280:DyaL1M%2FisVOiug%3D%3D 3178248 (Pubitemid 18260861)
19. Gunther C, Laske J, Frind A, Julius U, Pfeiffer C (2008) Successful therapy of pemphigus vulgaris with immunoadsorption using the TheraSorbtrade mark adsorber. J Dtsch Dermatol Ges
20. JE Herrero-Gonzalez C Sitaru E Klinker EB Brocker D Zillikens 2005 Successful adjuvant treatment of severe bullous pemphigoid by tryptophan immunoadsorption Clin Exp Dermatol 30 5 519 522 10.1111/j.1365-2230.2005.01853.x 1:STN:280:DC%2BD2MzoslCmtg%3D%3D 16045683 (Pubitemid 41076018)
21. F Hiepe B Pfuller K Wolbart A Bruns HP Leinenbach M Hepper W Schossler V Otto 1999 C1q: a multifunctional ligand for a new immunoadsorption treatment Ther Apher 3 3 246 251 1:CAS:528:DyaK1MXltVKjtbY%3D 10427623
22. N Ino N Kamata C Matsuura H Shinkai M Odaka 1997 Immunoadsorption for the treatment of bullous pemphigoid Ther Apher 1 4 372 376 10.1111/j.1744-9987. 1997.tb00059.x 1:STN:280:DyaK1M3ktValtw%3D%3D 10225735
23. H Iwata N Kamio Y Aoyama Y Yamamoto Y Hirako K Owaribe Y Kitajima 2009 IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment J Invest Dermatol 129 4 919 926 10.1038/jid.2008.305 1:CAS:528:DC%2BD1MXjs1Khsbg%3D 19177144
24. I Kaczmarek MA Deutsch S Sadoni P Brenner D Schmauss SH Daebritz M Weiss BM Meiser B Reichart 2007 Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review J Heart Lung Transplant 26 5 511 515 10.1016/j.healun.2007.01.027 17449422 (Pubitemid 46602000)
25. JG Kadar H Borberg 1990 Biocompatibility of extracorporeal immunoadsorption systems Transfus Sci 11 2 223 239 10.1016/0955-3886(90)90099-5 1:STN:280:DyaK38bgtFSgtg%3D%3D 10149537
26. Kasperkiewicz M, Hoppe U, Zillikens D, Schmidt E (2009) Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid. Clin Exp Dermatol (in press)
27. Kasperkiewicz M, Schmidt E, Rose C, Frambach, Anemüller W, Grabbe J, Ludwig R, Zillikens D (2009) Immunadsorption bei Patienten mit schwerster atopischer Dermatitis und exzessiv erhöhten peripheren Serum-IgE-Spiegeln. 82. Jahrestagung der Norddeutschen Dermatologischen Gesellschaft. 02.04.09.2009, Halle (Saale) (abstract)
28. P Knobl K Derfler 1999 Extracorporeal immunoadsorption for the treatment of haemophilic patients with inhibitors to factor VIII or IX Vox Sang 77 Suppl 1 57 64 1:CAS:528:DyaK1MXmslOmurk%3D 10529691
29. G Kumlien L Ullstrom A Losvall LG Persson G Tyden 2006 Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies Transfusion 46 9 1568 1575 10.1111/j.1537-2995.2006.00927.x 1:CAS:528:DC%2BD28XhtFSju7vI 16965585 (Pubitemid 44326333)
30. Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J (2008) Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: population based cohort study. BMJ 337:a180
31. Z Lazarova C Yee T Darling RA Briggaman KB Yancey 1996 Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice J Clin Invest 98 7 1509 1518 10.1172/JCI118942 1:CAS:528:DyaK28XmtVCmurY%3D 8833897
32. Z Liu LA Diaz JL Troy AF Taylor DJ Emery JA Fairley GJ Giudice 1993 A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180 J Clin Invest 92 5 2480 2488 10.1172/JCI116856 1:CAS:528:DyaK2cXivFWqug%3D%3D 7693763
33. Z Liu LA Diaz SJ Swartz JL Troy JA Fairley GJ Giudice 1995 Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid J Immunol 155 11 5449 5454 1:CAS:528:DyaK2MXpsF2it74%3D 7594563
34. GM Liumbruno PE Centoni P Molfettini S Ceretelli M Ceccarini L Bachini A Pomponi G Bagnoni M Vitolo O Eberle A Biondi ML Sodini 2006 Lymphocytapheresis in the treatment of psoriasis vulgaris J Clin Apher 21 3 158 164 10.1002/jca.20079 16425186 (Pubitemid 46579289)
35. M Luftl A Stauber A Mainka R Klingel G Schuler M Hertl 2003 Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber Br J Dermatol 149 3 598 605 10.1046/j.1365-2133.2003.05513.x 1:STN:280:DC%2BD3svkvFKgsg%3D%3D 14510995 (Pubitemid 37281594)
36. G Marazza HC Pham L Scharer PP Pedrazzetti T Hunziker RM Trueb D Hohl P Itin S Lautenschlager L Naldi L Borradori 2009 Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study Br J Dermatol 161 4 861 868 10.1111/j.1365-2133.2009.09300.x 1:STN:280:DC%2BD1MnkvVektg%3D%3D 19566661
37. A Marn Pernat J Buturovic-Ponikvar V Svigelj R Ponikvar 2009 Guillain-Barre syndrome treated by membrane plasma exchange and/or immunoadsorption Ther Apher Dial 13 4 310 313 10.1111/j.1744-9987.2009.00730.x 19695065
38. G Matic D Hofmann R Winkler M Tiess A Michelsen JM Schneidewind G Hebestreit M Keysser W Muller EM Kinze W Ramlow 2000 Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: evaluation of 602 sessions of extracorporeal immunoadsorption Artif Organs 24 2 103 107 10.1046/j.1525-1594.2000.06490.x 1:CAS:528:DC%2BD3cXktlGgsbo%3D 10718762 (Pubitemid 30408703)
39. K Mitsuyama M Sata 2009 Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of action Cytotherapy 11 2 229 237 10.1080/14653240902725566 1:CAS:528:DC%2BD1MXjsFeltrg%3D 19241197
40. GK Mulyowa G Jaeger J Kabakyenga EB Brocker D Zillikens E Schmidt 2006 Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients Int J Dermatol 45 9 1047 1052 10.1111/j.1365-4632.2006.02750.x 16961507 (Pubitemid 44317117)
41. A Nagel M Hertl R Eming 2009 B-cell-directed therapy for inflammatory skin diseases J Invest Dermatol 129 2 289 301 10.1038/jid.2008.192 1:CAS:528:DC%2BD1MXmt1Grtw%3D%3D 19148218
42. K Naito S Morioka H Ogawa 1982 The pathogenic mechanisms of blister formation in bullous pemphigoid J Invest Dermatol 79 5 303 306 10.1111/1523-1747.ep12500082 1:STN:280:DyaL3s%2Fjt1SgtA%3D%3D 6752292 (Pubitemid 12005685)
43. A Niedermeier R Eming M Pfutze CR Neumann C Happel K Reich M Hertl 2007 Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies) Arch Dermatol 143 2 192 198 10.1001/archderm.143.2.192 1:CAS:528:DC%2BD2sXjtVWgtLY%3D 17309999 (Pubitemid 46294584)
44. R Norda BG Stegmayr 2003 Therapeutic apheresis in Sweden: update of epidemiology and adverse events Transfus Apher Sci 29 2 159 166 10.1016/S1473-0502(03)00121-6 12941356 (Pubitemid 36993783)
45. K Ogata K Yasuda M Matsushita H Kodama 1999 Successful treatment of adolescent pemphigus vulgaris by immunoadsorption method J Dermatol 26 4 236 239 1:STN:280:DyaK1M3nsV2gtQ%3D%3D 10343469
46. S Ohji K Nomura 2008 The indication of steroid pulse therapy and apheresis therapy for multiple sclerosis Nippon Rinsho 66 6 1127 1132 18540358
47. M Pfutze R Eming A Kneisel U Kuhlmann J Hoyer M Hertl 2009 Clinical and immunological follow-up of pemphigus patients on adjuvant treatment with immunoadsorption or rituximab Dermatology 218 3 237 245 10.1159/000187431 19088461
48. S Pisanti Y Sharav E Kaufman LN Posner 1974 Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion Oral Surg Oral Med Oral Pathol 38 3 382 387 10.1016/0030-4220(74)90365-X 1:STN:280:DyaE2M%2FhtlertQ%3D%3D 4528670
49. P Poullin N Announ B Mugnier S Guis J Roudier P Lefevre 2005 Protein A-immunoadsorption (Prosorba column) in the treatment of rheumatoid arthritis Joint Bone Spine 72 2 101 103 10.1016/j.jbspin.2004.02.009 15797486 (Pubitemid 41388958)
50. J Rech AJ Hueber S Kallert J Leipe JR Kalden M Beck G Schett H Schulze-Koops 2008 Remission of demyelinating polyneuropathy with immunoadsorption, low dose corticosteroids and anti-CD20 monoclonal antibody Ther Apher Dial 12 3 205 208 10.1111/j.1744-9987.2008.00573.x 1:CAS:528:DC%2BD1cXoslOqt70%3D 18503697 (Pubitemid 351743599)
51. W Ronspeck R Brinckmann R Egner F Gebauer D Winkler P Jekow G Wallukat J Muller R Kunze 2003 Peptide based adsorbers for therapeutic immunoadsorption Ther Apher Dial 7 1 91 97 10.1046/j.1526-0968.2003.00017.x 12921122 (Pubitemid 36648050)
52. JC Roujeau J Revuz R Touraine M Joneau-Fabre P Mannoni 1979 Cortico-resistant bullous pemphigoid: favorable results with plasmapheresis Nouv Presse Med 8 41 3362 1:STN:280:DyaL3c7gtV2kuw%3D%3D 392462
53. JC Roujeau C Andre M Joneau Fabre P Lauret ML Flechet B Kalis J Revuz R Touraine 1983 Plasma exchange in pemphigus: uncontrolled study of ten patients Arch Dermatol 119 3 215 221 10.1001/archderm.119.3.215 1:STN:280: DyaL3s7isFKltQ%3D%3D 6824359 (Pubitemid 13151963)
54. Y Sakai S Sakai T Otsuka D Ohno T Murasawa K Munakata K Mizuno 2009 Efficacy of high-throughput leukocytapheresis for rheumatoid arthritis with a reduced response to infliximab Ther Apher Dial 13 3 179 185 10.1111/j.1744-9987. 2009.00657.x 19527463
55. K Sawada T Muto T Shimoyama M Satomi T Sawada H Nagawa N Hiwatashi H Asakura T Hibi 2003 Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column Curr Pharm Des 9 4 307 321 10.2174/1381612033391928 1:CAS:528:DC%2BD3sXksl2nug%3D%3D 12570823 (Pubitemid 36131725)
56. JR Schiltz B Michel 1976 Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum J Invest Dermatol 67 2 254 260 10.1111/1523-1747.ep12513454 1:STN:280:DyaE283jvFersQ%3D%3D 950490
57. E Schmidt K Obe EB Brocker D Zillikens 2000 Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid Arch Dermatol 136 2 174 178 10.1001/archderm.136.2.174 1:CAS:528:DC%2BD3cXhsVaqsLg%3D 10677092
58. E Schmidt E Klinker A Opitz S Herzog C Sitaru M Goebeler B Mansouri Taleghoni EB Brocker D Zillikens 2003 Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus Br J Dermatol 148 6 1222 1229 10.1046/j.1365-2133.2003.05302.x 1:CAS:528:DC%2BD3sXmt12gsbc%3D 12828752 (Pubitemid 36819223)
59. E Schmidt EB Brocker M Goebeler 2008 Rituximab in treatment-resistant autoimmune blistering skin disorders Clin Rev Allergy Immunol 34 1 56 64 10.1007/s12016-007-8021-6 1:CAS:528:DC%2BD1cXkt1Kmur4%3D 18270859
60. E Schmidt M Goebeler D Zillikens 2009 Rituximab in severe pemphigus Ann N Y Acad Sci 1173 9 683 691 10.1111/j.1749-6632.2009.04744.x 1:CAS:528: DC%2BD1MXhtlCnt7zP 19758216
61. E Schmidt D Zillikens 2009 Research in practice: diagnosis of subepidermal autoimmune bullous disorders J Dtsch Dermatol Ges 7 4 296 300 19192160
62. H Schoen D Foedinger K Derfler G Amann K Rappersberger G Stingl B Volc-Platzer 1998 Immunoapheresis in paraneoplastic pemphigus Arch Dermatol 134 6 706 710 10.1001/archderm.134.6.706 1:STN:280:DyaK1czgslGntA%3D%3D 9645639 (Pubitemid 28283722)
63. I Shimanovich S Herzog E Schmidt A Opitz E Klinker EB Brocker M Goebeler D Zillikens 2006 Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption Clin Exp Dermatol 31 6 768 774 10.1111/j.1365-2230. 2006.02220.x 1:STN:280:DC%2BD28ngslKqug%3D%3D 16824051 (Pubitemid 44563392)
64. I Shimanovich M Nitschke C Rose J Grabbe D Zillikens 2008 Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins Br J Dermatol 158 2 382 388 1:CAS:528:DC%2BD1cXivVSisrw%3D 18070210
65. I Shimanovich AK Bohmke L Westermann J Kramer D Zillikens E Schmidt 2009 Successful treatment of severe pemphigus with the combination of immunoadsorption and rituximab J Invest Dermatol 129 S97
66. C Sitaru A Kromminga T Hashimoto EB Brocker D Zillikens 2002 Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin Am J Pathol 161 1 301 311 1:CAS:528:DC%2BD38Xlsl2ksL8%3D 12107115
67. C Sitaru E Schmidt S Petermann LS Munteanu EB Brocker D Zillikens 2002 Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin J Invest Dermatol 118 4 664 671 10.1046/j.1523-1747.2002.01720.x 1:CAS:528:DC%2BD38Xjt1Cisrs%3D 11918714 (Pubitemid 34309987)
68. C Sitaru S Mihai C Otto MT Chiriac I Hausser B Dotterweich H Saito C Rose A Ishiko D Zillikens 2005 Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen J Clin Invest 115 4 870 878 1:CAS:528:DC%2BD2MXjtFyltr0%3D 15841176
69. C Sitaru MT Chiriac S Mihai J Buning A Gebert A Ishiko D Zillikens 2006 Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice J Immunol 177 5 3461 3468 1:CAS:528:DC%2BD28Xot1Cjtbo%3D 16920988
70. H Soerensen JM Schneidewind-Mueller D Lange N Kashiwagi M Franz T Yokoyama W Ramlow 2006 Pilot clinical study of Adacolumn cytapheresis in patients with systemic lupus erythematosus Rheumatol Int 26 5 409 415 10.1007/s00296-005-0031-1 16189656
71. K Sondergaard J Carstens J Jorgensen H Zachariae 1995 The steroid-sparing effect of long-term plasmapheresis in pemphigus Acta Derm Venereol 75 2 150 152 1:STN:280:DyaK2MzivVeltg%3D%3D 7604647
72. R Tan-Lim JC Bystryn 1990 Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies J Am Acad Dermatol 22 1 35 40 10.1016/0190-9622(90)70004-2 1:STN:280:DyaK3c7jtFarsQ%3D%3D 2298963
73. MS Turner D Sutton DN Sauder 2000 The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris J Am Acad Dermatol 43 6 1058 1064 10.1067/mjd.2000.109297 1:STN:280:DC%2BD3M%2Fptl2rtg%3D%3D 11100023
74. G Wallukat J Muller R Hetzer 2002 Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy N Engl J Med 347 22 1806 10.1056/NEJM200211283472220 12456865 (Pubitemid 35375628)
75. J Waschke 2008 The desmosome and pemphigus Histochem Cell Biol 130 1 21 54 10.1007/s00418-008-0420-0 1:CAS:528:DC%2BD1cXmtlWit7w%3D 18386043
76. S Wohrl A Geusau F Karlhofer K Derfler G Stingl D Zillikens 2003 Pemphigoid gestationis: treatment with immunoapheresis J Dtsch Dermatol Ges 1 2 126 130 16285180
77. DT Woodley R Ram A Doostan P Bandyopadhyay Y Huang J Remington Y Hou DR Keene Z Liu M Chen 2006 Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients J Invest Dermatol 126 6 1323 1330 10.1038/sj.jid.5700254 1:CAS:528:DC%2BD28Xls1Ghtrg%3D 16543893 (Pubitemid 43997915)
78. D Zillikens K Derfler R Eming G Fierlbeck M Goebeler M Hertl SC Hofmann F Karlhofer O Kautz M Nitschke A Opitz S Quist C Rose S Schanz E Schmidt I Shimanovich M Michael F Ziller 2007 Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases J Dtsch Dermatol Ges 5 10 881 887 10.1111/j.1610-0387.2007.06342.x 17910670 (Pubitemid 47546368)
79. AM Abreu-Velez MS Howard K Hashimoto T Hashimoto 2009 Autoantibodies to sweat glands detected by different methods in serum and in tissue from patients affected by a new variant of endemic pemphigus foliaceus Arch Dermatol Res 301 711 718 10.1007/s00403-009-0972-4 1:CAS:528:DC%2BD1MXhtFCjtb7K 19547994
80. E Gaines VP Werth 2008 Development of outcome measures for autoimmune dermatoses Arch Dermatol Res 300 3 9 10.1007/s00403-007-0813-2 1:CAS:528:DC%2BD2sXhtl2ks7bP 17985101 (Pubitemid 50001024)
81. L Leighty N Li LA Diaz Z Liu 2007 Experimental models for the autoimmune and inflammatory blistering disease: bullous pemphigoid Arch Dermatol Res 299 417 422 10.1007/s00403-007-0790-5 1:CAS:528:DC%2BD2sXhtFaqu7fN 17879094 (Pubitemid 47546926)
82. AL Nancy S Yehuda 2009 Prediction and prevention of autoimmune skin disorders Arch Dermatol Res 301 57 64 10.1007/s00403-008-0889-3 18815800